News
Germany's Merck KGaA agreed to acquire U.S. biopharmaceutical company SpringWorks Therapeutics for around $3.9 billion, in a bid to expand its oncology and rare disease business. The German life ...
Behind declines for shares of Merck and Goldman Sachs, the Dow Jones Industrial Average is declining Wednesday morning. Supported by world-class markets data from Dow Jones and FactSet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback